Vital KSK Holdings (TSE:3151) Current Deferred Revenue: 円0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:3151 Vital KSK Holdings Inc TSE:3151
64 GF Score
Price 円1,592.00
GF Value 円1,329.43
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Vital KSK Holdings Current Deferred Revenue?

Vital KSK Holdings TSE:3151 +0.38% 64 Current Deferred Revenue is 円0 Mil as of Mar. 2026. GuruFocus rates TSE:3151 with a GF Score™ of 64/100 and a GF Value™ of 円1,329.43 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Vital KSK Holdings's current deferred revenue for the quarter that ended in Mar. 2026 was 円0 Mil.

Vital KSK Holdings Current Deferred Revenue Related Terms

Vital KSK Holdings Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Vital KSK Holdings's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vital KSK Holdings Current Deferred Revenue Chart

Vital KSK Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Vital KSK Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:3151
64GF Score
Vital KSK Holdings Inc TSE:3151
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of 円0 Mil mean?
Vital KSK Holdings (TSE:3151) has a Current Deferred Revenue of 円0 Mil as of Mar. 2026. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Vital KSK Holdings and its competitors.
Is Vital KSK Holdings' Current Deferred Revenue too high?
Vital KSK Holdings' current Current Deferred Revenue is 円0 Mil. Overall, Vital KSK Holdings has a GF Score™ of 64/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vital KSK Holdings' Current Deferred Revenue compare to MCK and COR?
Vital KSK Holdings' Current Deferred Revenue of 円0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Medical Distribution company?
A good Current Deferred Revenue depends on the Medical Distribution industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Vital KSK Holdings and its competitors. Vital KSK Holdings's current Current Deferred Revenue is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vital KSK Holdings stock overvalued right now?
Based on GuruFocus' analysis, Vital KSK Holdings (TSE:3151) is currently considered Modestly Overvalued. The stock's GF Value™ is 円1,329.43, compared to a current price of 円1,592.00 — trading 19.8% above its estimated fair value. The current Current Deferred Revenue is 円0 Mil. Vital KSK Holdings' overall GF Score™ is 64/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Vital KSK Holdings (TSE:3151), the current Current Deferred Revenue is 円0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vital KSK Holdings (TSE:3151) Overvalued in 2026?

Based on GuruFocus' analysis, Vital KSK Holdings stock appears to be overvalued. The current stock price of 円1,592.00 is trading 19.8% above its estimated GF Value™ of 円1,329.43. GuruFocus considers Vital KSK Holdings to be Modestly Overvalued.

Key valuation signals for TSE:3151:

  • Current Deferred Revenue: 円0 Mil
  • GF Value™: 円1,329.43 vs. price of 円1,592.00 (19.8% above fair value)
  • GF Score™: 64/100 with 6 warning signs

No single metric tells the full story. See the TSE:3151 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vital KSK Holdings Business Description

Address 1-1-12 Tsurumaki, Setagaya-ku, JPN, 154-0016
Vital KSK Holdings Inc engaged in the wholesale and retail of pharmaceutical products. It operates through the Pharmaceutical Wholesale and Other segments. The Pharmaceutical Wholesale segment sells medicines, diagnostics, and medical devices to hospitals, medical institutions, and health practitioners. The Other segment includes retail of pharmaceutical products, wholesale of agrochemical and veterinary drugs, transportation, nursing care services, and medical consultancies. All the business activity of the group is primarily functioned through Japan and distributes its product within the Korean and to overseas market.
64GF Score

Get the complete analysis for TSE:3151

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,592.00
Price
円1,329.43
GF Value